MANCHESTER, England, February 5 /PRNewswire/ -- Epistem plc (LSE:EHP) announced today that it had successfully completed a preliminary study with AstraZeneca for the use of its proprietary,…

PLANEGG-MARTINSRIED, Germany, February 5 /PRNewswire/ -- The Martinsried drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC) and the Wuppertal-based AiCuris GmbH & Co…

A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus (HCV) from infected cells, a process required to maintain chronic…

A new plan to further reduce, refine and replace the use of animals in research and regulatory testing, commonly referred to as the 3Rs, was unveiled today by the Interagency Coordinating Committee…

VEENENDAAL, The Netherlands, February 4 /PRNewswire/ -- Nucletron BV and clinicians at The Cancer Centre, Northern Ireland, proudly report the first IMRT clinical treatment within the Conventional…

CALGARY, Canada, February 4 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ('Oncolytics') reported today that Dr. Kevin Harrington and his research group at The Institute of Cancer…

Continued from Part 4: I interviewed Gary Taubes by phone a few weeks ago, shortly after he gave a talk about the main ideas of his new book — Good Calories, Bad Calories — at UC Berkeley. The…

Gout, or metabolic arthritis, was considered by Hippocrates “the disease of kings” because only wealthy people with rich diets got it. This was true until the early 20th century when cases went down…

A new study may explain why women with a mutation in the BRCA1 gene face up to an 85 percent lifetime risk of breast cancer; researchers from the University of Michigan Comprehensive Cancer Center…

PRINCETON, New Jersey, January 31 /PRNewswire/ -- - Laureate to Manufacture ARIUS' Product Candidate Trop-2 Signal Transduction Antibody Laureate Pharma, Inc., a full-service biopharmaceutical…